CA2274661A1 - Hydrogel ameliore pour la creation de tissu - Google Patents

Hydrogel ameliore pour la creation de tissu Download PDF

Info

Publication number
CA2274661A1
CA2274661A1 CA002274661A CA2274661A CA2274661A1 CA 2274661 A1 CA2274661 A1 CA 2274661A1 CA 002274661 A CA002274661 A CA 002274661A CA 2274661 A CA2274661 A CA 2274661A CA 2274661 A1 CA2274661 A1 CA 2274661A1
Authority
CA
Canada
Prior art keywords
hydrogel
composition
alginate
soluble salt
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002274661A
Other languages
English (en)
Inventor
Kermit M. Borland
Tao Zhou
Gordon P. Nelson
Daniel R. Omstead
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Curis Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2274661A1 publication Critical patent/CA2274661A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention porte sur des compostions destinées à être implantées chez un animal et comprenant un polymère biodégradable, biocompatible, qui forme un hydrogel lors de la réticulation. Selon un mode préféré, le polymère est réticulé par des ions multivalents, plus souhaitablement, un sel soluble d'un ion multivalent et un sel modérément soluble d'un ion multivalent, ces composants étant combinés pour obtenir un mélange formant un hydrogel injectable, partiellement durci, la consistance du mélange étant appropriée pour implanter le mélange d'hydrogel partiellement durci chez un animal. Cet hydrogel implanté, partiellement durci, forme in situ un hydrogel totalement durci. De préférence, le mélange contient également un agent séquestrant biocompatible qui rivalise avec le polymère biocompatible dans la liaison de l'ion de réticulation multivalent. Cette composition peut ou peut ne pas contenir de cellules vivantes. L'invention porte également sur des procédés d'implantation de la composition chez un animal, celle-ci pouvant être un implant contenant des cellules vivantes.
CA002274661A 1996-12-10 1997-12-10 Hydrogel ameliore pour la creation de tissu Abandoned CA2274661A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US76273396A 1996-12-10 1996-12-10
US08/762,733 1996-12-10
US5108497P 1997-06-27 1997-06-27
US60/051,084 1997-06-27
US5955897P 1997-09-19 1997-09-19
US60/059,558 1997-09-19
PCT/US1997/022859 WO1998025653A2 (fr) 1996-12-10 1997-12-10 Hydrogel ameliore pour la creation de tissu

Publications (1)

Publication Number Publication Date
CA2274661A1 true CA2274661A1 (fr) 1998-06-18

Family

ID=27367902

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002274661A Abandoned CA2274661A1 (fr) 1996-12-10 1997-12-10 Hydrogel ameliore pour la creation de tissu

Country Status (5)

Country Link
EP (1) EP0944403A2 (fr)
JP (1) JP4002299B2 (fr)
AU (1) AU742316B2 (fr)
CA (1) CA2274661A1 (fr)
WO (1) WO1998025653A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999051164A1 (fr) 1998-04-03 1999-10-14 Reprogenesis, Inc. Dispositif de reconstruction des tissus mous et son procede d'utilisation
US6761887B1 (en) * 1998-11-16 2004-07-13 Osiris Therapeutics, Inc. Alginate layer system for chondrogenic differentiation of human mesenchymal stem cells
AU1626500A (en) * 1998-11-16 2000-06-05 Osiris Therapeutics, Inc. Alginate layer system for chondrogenic differentiation of human mesenchymal stemcells
IT1311576B1 (it) 1999-10-25 2002-03-13 Ghimas Spa Dispositivo medico invasivo, in particolare per la rigenerazionetissutale guidata.
US20040106896A1 (en) * 2002-11-29 2004-06-03 The Regents Of The University Of California System and method for forming a non-ablative cardiac conduction block
WO2007015761A2 (fr) * 2005-07-21 2007-02-08 Fmc Biopolymer As Dispositifs medicaux revetus d'un revetement biocompatible a dissolution rapide
AU2008217916B2 (en) * 2007-02-21 2013-03-21 Mochida Pharmaceutical Co., Ltd. Composition for treatment of cartilage disease
JP5161482B2 (ja) * 2007-05-09 2013-03-13 オリンパス株式会社 生体組織補填材の製造方法
IL187707A0 (en) * 2007-11-27 2008-11-03 Univ Ben Gurion Alginate scaffold in hepatectomy
US8367637B2 (en) 2008-08-19 2013-02-05 Mochida Pharmaceutical Co., Ltd. Composition for treating arthritic disorder
US9308070B2 (en) 2008-12-15 2016-04-12 Allergan, Inc. Pliable silk medical device
US20110020409A1 (en) 2009-04-20 2011-01-27 Altman Gregory H Silk Fibroin Hydrogels and Uses Thereof
WO2017044896A1 (fr) * 2015-09-09 2017-03-16 Dsm Ip Assets B.V. Compositions d'adhésis et de produits de scellement biomédicaux et leurs procédés d'utilisation
CN116270441A (zh) * 2016-04-01 2023-06-23 波士顿科学国际有限公司 可注射组合物及其制备和使用方法
WO2020096281A1 (fr) * 2018-11-06 2020-05-14 국립암센터 Système d'hydrogel injectable à base d'acide alginique
CN114269396A (zh) * 2019-08-27 2022-04-01 克朗医疗有限公司 作为临时栓塞剂的基于藻酸盐的颗粒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352883A (en) 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US5041138A (en) 1986-11-20 1991-08-20 Massachusetts Institute Of Technology Neomorphogenesis of cartilage in vivo from cell culture
JPS63177791A (ja) 1987-01-16 1988-07-21 Kibun Kk 固定化酵素又は固定化微生物の製造法
DE4103876C2 (de) * 1990-02-09 1994-07-07 Asahi Optical Co Ltd Verfahren zur Fixierung einer körnigen Knochen-Prothese und Kit zur Herstellung einer körnigen Knochen-Prothesezusammensetzung zur Verwendung in dem Fixierungsverfahren
NO171069C (no) * 1990-05-29 1993-01-20 Protan Biopolymer As Kovalent tverrbundne, sterkt svellende alkalimetall- og ammonium-alginatgeler, samt fremgangsmaate for fremstilling derav
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5658329A (en) * 1995-02-14 1997-08-19 Mentor Corporation Filling material for soft tissue implant prostheses and implants made therewith
US6129761A (en) * 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
ATE258810T1 (de) * 1995-11-09 2004-02-15 Univ Massachusetts Wiederherstellung der gewebeoberfläche mit zusammensetzungen aus hydrogel-zellen

Also Published As

Publication number Publication date
EP0944403A2 (fr) 1999-09-29
WO1998025653A2 (fr) 1998-06-18
AU742316B2 (en) 2001-12-20
JP2001505809A (ja) 2001-05-08
AU5698698A (en) 1998-07-03
WO1998025653A3 (fr) 1998-10-15
JP4002299B2 (ja) 2007-10-31

Similar Documents

Publication Publication Date Title
AU743690B2 (en) Improved hydrogel for tissue engineering
US6730298B2 (en) Tissue formation by injecting a cell-polymeric solution that gels in vivo
JP6762936B2 (ja) 軟骨修復のための移植片足場及びその製造方法
EP1799232B1 (fr) Systemes d'alginate auto-gelifiants et utilisations associees
Kuo et al. Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: Part 1. Structure, gelation rate and mechanical properties
US6991652B2 (en) Tissue engineering composite
AU742316B2 (en) Improved hydrogel for tissue engineering
EP2025353A2 (fr) Compositions de cellules de polysaccharide injectables
JP2002503230A (ja) 薬物送達及び組織工学のためのセミ相互侵入又は相互侵入ポリマー網目構造
JPH10510736A (ja) 胸部組織強化技術
TW200403268A (en) Biodegradable polyurethane/urea compositions
CA2212300A1 (fr) Gelification in vitro ou in vivo du chitosane et utilisations therapeutiques du chitosane
JP5319524B2 (ja) 架橋治療用組成物を製造するためのゼラチンおよび架橋剤の使用
JP2008043782A (ja) 注入可能な多糖類−細胞組成物
WO1999051164A1 (fr) Dispositif de reconstruction des tissus mous et son procede d'utilisation
US6872387B1 (en) Three-dimensional hydrogel/cell system
WO1998025575A2 (fr) Composition d'hydrogel amelioree
EP4382142A1 (fr) Composition pour la préparation d'un hydrogel complexe organique-inorganique et kit pour la préparation d'un hydrogel complexe organique-inorganique la comprenant

Legal Events

Date Code Title Description
FZDE Discontinued